Marco Brughera

Marco Brughera

Directeur/Membre du Conseil chez FENNEC PHARMACEUTICALS INC.

Fortune : - $ au 31/07/2026

70 ans
Health Technology
Consumer Services
Producer Manufacturing

Profil

Marco Maria Brughera is Chief Executive Officer at Prassis - Istituto di Ricerche Sigma-Tau SpA since 2011.
Dr. Brughera is Independent Director at Fennec Pharmaceuticals, Inc. since 2016.
Dr. Brughera is Director at Exelead, Inc. Dr. Brughera is Director at Leadiant Biosciences Ltd. Dr. Brughera is Director at Naicons Srl.
Former roles include President & Chief Executive Officer at Tecnogen SpA, Chief Executive Officer & Head-Rare Disease at Sigma Tau Rare Diseases SA, Chief Executive Officer & Director at Servier IP UK Ltd., Chief Executive Officer & Director at Leadiant Biosciences SpA from 2011 to 2021, Independent Director at Soligenix, Inc., Managing Director-Corporate Research & Development at Essetifin SpA from 2012 to 2013, Non-Executive Director at Lee's Pharmaceutical Holdings Ltd. from 2014 to 2017, Director at Gentium Srl from 2011 to 2014, President & Director at Leadiant Biosciences, Inc., Managing Director at Accelera Srl from 2004 to 2010, Vice President-Preclinical Development at Nerviano Medical Sciences Srl from 2004 to 2010, MD-Corporate Research & Development at Sigma-Tau Industrie Farmaceutiche Riunite SpA from 2011 to 2012, and President at Sigma-Tau Research Switzerland SA from 2011 to 2012.
Education includes a doctorate from the University of Milan conferred in 1981.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
10/06/2026 0 ( -.--% ) - $ 31/07/2026

Postes actifs de Marco Brughera

SociétésPosteDébut
FENNEC PHARMACEUTICALS INC. Directeur/Membre du Conseil 10/08/2016
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Prassis - Istituto di Ricerche Sigma-Tau SpA
Directeur Général 01/01/2011
Directeur/Membre du Conseil -

Anciens postes connus de Marco Brughera

SociétésPosteFin
Directeur Général 01/11/2021
LEE'S PHARMACEUTICAL HOLDINGS LIMITED Directeur/Membre du Conseil 29/12/2017
GENTIUM S.P.A. (ADR) Directeur/Membre du Conseil 01/01/2014
Corporate Officer/Principal 01/10/2012
░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Marco Brughera

Formation de Marco Brughera

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

69

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Producer Manufacturing

Health Technology

Prassis - Istituto di Ricerche Sigma-Tau SpA

Sigma Tau Rare Diseases SA

Distribution Services

Health Technology

Health Technology

Health Technology

Technology Services

  1. Bourse
  2. Insiders
  3. Marco Brughera